Celex is a leading biotechnology company focused on the research and development of cutting-edge cancer treatments. Our team of experienced scientists and physicians are dedicated to improving the lives of those affected by cancer through the discovery and development of innovative therapeutics.
Utilising cutting-edge technology, developed by Professor Djamgoz over the course of 20 years of research, and a deep understanding of the underlying biology of cancer, we strive to bring new and effective treatment options to patients in need.
Celex Oncology is committed to advancing the fight against cancer and improving the lives of those affected by this disease.
Get in touch with the team today to learn more about our revolutionary therapeutics.
Celex Oncology are currently raising capital to advance our research and make invasive tumours benign. Contact us to learn more!
Company Details
- Employees
- 11
- Address
- London, Sw6 4nz, Gb
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- https://www.celexoncology.com/
- Keywords
- Geneva.
- HQ
- London
Celex Oncology Innovations Ltd Questions
Celex Oncology Innovations Ltd's website is https://www.celexoncology.com/
Celex Oncology Innovations Ltd's LinkedIn profile is https://uk.linkedin.com/company/celex-oncology-innovations-ltd
Celex Oncology Innovations Ltd has
11 employees.
View email and phone details for 11
employees at Celex Oncology Innovations Ltd.
Celex Oncology Innovations Ltd's industry is
Hospitals and Health Care
Celex Oncology Innovations Ltd's top competitors are
Zumper,
Alkamis,
Salica Investments,
Polygon Therapeutics,
Acorai,
Eit Health,
Broadgate Advisers,
Gelmetix,
Dymium,
Solascure.
Celex Oncology Innovations Ltd's categories are Hospitals and Health Care
